DOI:
10.1055/s-00033990
TH Open
LinksSchließen
Referenz
Wiviott SD, Braunwald E, Angiolillo DJ. , et al; TRITON-TIMI 38 Investigators.
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Circulation 2008;
118 (16) 1626-1636
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.